Lipocine Inc. (LPCN)

Lipocine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5.21	6.21	4.77	3.15	2.95
Short-Term Investments	9.72	15.43	17.26	29.38	41.67
Cash & Short-Term Investments	14.93	21.63	22.04	32.53	44.62
Cash Growth	-30.98%	-1.82%	-32.26%	-27.09%	126.86%
Other Receivables	1.16	0.21	0.05	0.08	0.25
Total Trade Receivables	1.16	0.21	0.05	0.08	0.25
Other Current Assets	0.79	0.48	0.77	1.52	1.51
Total Current Assets	16.88	22.32	22.86	34.14	46.38
Net Property, Plant & Equipment	0.1	0.17	0.12	0.13	0.01
Long-Term Investments	-	-	-	-	2.02
Other Long-Term Assets	0.02	0.02	0.02	3.28	4.07
Total Assets	17.01	22.51	23	37.54	52.48
Accounts Payable	0.97	0.27	1.4	0.6	1.29
Accrued Expenses	1.24	0.92	1.22	1.08	1.02
Current Portion of Long-Term Debt	-	-	-	-	2.31
Unearned Revenue	0.32	0.32	-	-	-
Other Current Liabilities	-	-	0.02	-	1
Total Current Liabilities	2.53	1.51	2.63	1.68	5.62
Other Long-Term Liabilities	-	-	-	0.23	1.3
Total Long-Term Liabilities	-	-	-	0.23	1.3
Total Liabilities	2.53	1.51	2.63	1.91	6.91
Common Stock	0.01	0.01	0.01	0.01	0.01
Treasury Stock	-0.04	-0.04	-0.04	-0.04	-0.04
Additional Paid-in Capital	223.9	220.79	220.17	219.11	218.29
Accumulated Other Comprehensive Income	0	0.01	0.01	-0.02	-0.02
Retained Earnings	-209.4	-199.77	-199.78	-183.43	-172.67
Shareholders' Equity	14.48	21	20.37	35.63	45.57
Total Liabilities & Equity	17.01	22.51	23	37.54	52.48
Total Debt	0	0	0	0	2.31
Net Cash (Debt)	14.93	21.63	22.04	32.53	42.31
Net Cash Growth	-30.98%	-1.82%	-32.26%	-23.11%	200.54%
Net Cash Per Share	2.62	3.99	4.18	6.19	8.21
Book Value	14.48	21	20.37	35.63	45.57
Book Value Per Share	2.54	3.87	3.87	6.78	8.84
Tangible Book Value	14.48	21	20.37	35.63	45.57
Tangible Book Value Per Share	2.54	3.87	3.87	6.78	8.84

Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q